抗体
药理学
药品
免疫原性
效价
化学
医学
免疫学
作者
Michael A. K. Partridge,Elif Kabuloglu Karayusuf,Gary Shyu,Camille Georgaros,Albert Torri,Giane Sumner
出处
期刊:Aaps Journal
[Springer Science+Business Media]
日期:2020-08-17
卷期号:22 (5): 112-112
被引量:11
标识
DOI:10.1208/s12248-020-00497-2
摘要
Neutralizing anti-drug antibody (NAb) assays often have lower drug tolerance (DT) than trough drug concentrations, potentially under-estimating NAb incidence. To improve DT, drug-specific proteins were coupled to magnetic beads to deplete drug in the sample. To avoid interference from carryover, drug-specific proteins that did not interfere in the NAb assay, such as target or non-blocking anti-drug antibodies, were selected. With the drug depletion step, DT improved by > 10-fold in two competitive ligand binding NAb assays. Analysis of anti-drug antibody positive clinical samples with elevated drug levels demonstrated that NAb incidence was under-estimated without the drug depletion step. However, these NAb-positive samples had low titer and no impact on drug concentrations.
科研通智能强力驱动
Strongly Powered by AbleSci AI